Long COVID Trial, Recruiting NCT05822193 Sponsor: Inova Medical Condition: Long COVID
Back to Long Covid

Long COVID Trial, Recruiting

NCT05822193
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 18 years old or older
  • You must live in Brazil
  • You must have had COVID-19 confirmed by an official test (either a PCR test or an antigen/rapid test), caught after January 2022, and your diagnosis must have been at least 90 days before joining the trial

Who may not be able to join:

  • You are not able to attend research appointments held remotely (such as by video or phone call)
  • You have difficulty communicating, for example due to a speech disorder, significant hearing loss, not speaking Portuguese, or severe memory/thinking problems (confirm with trial site)
  • You do not wish to give your formal agreement to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +5551994408818

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Inova Medical
Registry
ClinicalTrials.gov
Start date
21 July 2023
Est. completion
1 July 2025

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Post COVID-19 condition according to the WHO definition; EQ5D-3L

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov